TTK Healthcare Limited
NSE: TTKHLTCAREDiversified
Share price
₹1,016.60
+0.95% close of 9 Oct 2026
Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 8 Oct 2026, the close above is 9 Oct 2026.
Business score
How strong the business is, in one number. The parts behind it are in Pro.
44
out of 100 · worked out 8 Oct 2026
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹1,423 Cr
P/E ratio
19.2
P/B ratio
1.3
ROCE
8.0%
ROE
6.1%
Dividend yield
1.0%
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
How fast it has been growing
Sales grew 8.3% over the past year, and 8.0% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales improved from 3.0% to 4.2% over the last four years.
Whether it grew faster than its sector
It grew 8.0% a year against a sector median of 8.6% — 0.6 percentage points slower.
Room to re-rate, or risk of de-rating
At 19.1× earnings against a market that pays 23.9× across 2199 companies we can price. Its own industry sits at 10.9×, across 5 companies. It is against its own five-year median of 26.2×, the 8th percentile of its own range.
Whether growth justifies the valuation
Its earnings are falling, so growth cannot justify the price.
| Profit growth | Price per ₹1 profit | Per 1% growth | |
|---|---|---|---|
| TTK Healthcare Limited — this one | -52%/yr | 19.1× | — |
| 3M India Limited | 9%/yr | 57.2× | ₹6.4 |
| Godrej Industries Limited | 5%/yr | 28.4× | ₹5.7 |
| DCM Shriram Limited | -1%/yr | 10.8× | — |
| Balmer Lawrie & Company Limited | 17%/yr | 9.5× | ₹0.56 |
| Empire Industries Limited | 15%/yr | 10.9× | ₹0.73 |
Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
How it compares with its peers
Against companies the exchange files under the same label (Diversified), it ranks 7 of 7 on returns, 5 of 7 on growth, 7 of 7 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
What makes it hard to beat — and is that still true?
No durable advantage shows in the numbers: it earns 8.0% on capital, ahead of 0% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
Whether its growth pays for itself
No — Over the last five years the business itself consumed ₹10 crore of cash before any plant spend. But only about 23 of every 100 rupees of profit it reported over 12 years arrived as cash — the rest is tied up. Its cash comes back more slowly than it used to: it went from being paid 28 days before it paid its own suppliers to waiting 161 days for its cash.
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
7 of 9 checks clear · 78%
Latest result · Q1 FY27
What the last results showed. Whether management kept its word is in Pro.
Announced 6 Aug 2026 · Standalone · Unaudited
Revenue
₹258 Cr
Revenue vs last year
+14.0%
Revenue vs last quarter
+18.1%
Net profit
₹21 Cr
Profit vs last year
+63.7%
Profit vs last quarter
-3.3%
Net margin
8.3%
EPS
₹15.06
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹1,423 Cr
- Prev close
- ₹1,016.60
- 52w High
- ₹1,247
- 52w Low
- ₹735
- Enterprise value
- ₹814 Cr
- Beta
- 0.7
- Price CAGR 1y
- -10.0%
- Price CAGR 3y
- -2.0%
- Price CAGR 5y
- 9.0%
- Price CAGR 10y
- 0.0%
Ratios
- Return on assets
- 5.0%
- PEG ratio
- -0.4
- P/E ratio
- 19.2
- P/B ratio
- 1.3
- EV / EBITDA
- 21.4
- Industry P/E
- 13.4
- ROCE
- 8.0%
- ROCE 5y average
- 8.8%
- ROE
- 6.1%
- Debt / Equity
- 0.0
- Interest coverage
- 28.7
- Dividend yield
- 1.0%
- ROE 3y average
- 7.0%
- ROE last year
- 6.0%
Annual P&L
- Annual revenue
- ₹857 Cr
- Annual profit
- ₹66 Cr
- Operating margin
- 3.0%
- Net profit margin
- 7.7%
- EBITDA margin
- 3.0%
- Sales growth 3y
- 5.7%
- Sales growth 5y
- 12.5%
- Profit growth 3y
- -52.0%
- Profit growth 5y
- 11.0%
- EPS
- ₹46.5
- Sales growth TTM
- 8.0%
- Profit growth TTM
- 14.0%
- Dividend payout
- 22.0%
Quarter P&L
- Sales latest quarter
- ₹258 Cr
- Profit latest quarter
- ₹21 Cr
- YoY quarterly sales growth
- 13.7%
- YoY quarterly profit growth
- 61.5%
- OPM latest quarter
- 5.7%
Balance Sheet
- Book Value
- ₹796
- Face Value
- ₹10.0
- Total debt
- ₹24 Cr
- Total cash
- ₹633 Cr
- Borrowings
- ₹24 Cr
- Reserves / Equity
- 78.6
Cash Flow
- Operating cash flow
- -₹21 Cr
- Free cash flow
- -₹25 Cr
- FCF yield
- -1.9%
- Net cash flow
- ₹13 Cr
Shareholding
- Promoter holding
- 74.6%
- FII holding
- 1.9%
- DII holding
- 2.2%
- Public holding
- 21.4%
Peer comparison
| Company | Price ₹ | P/E | Mkt cap ₹ Cr | Div yield % | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|---|---|
| 3M India | 30,195.00 | 77.2 | 34,030 | 0.53 | 233.1 | -0.4 | 1,423.2 | 19.0 | 50.0 |
| Godrej Industrie | 1,010.00 | 28.3 | 34,022 | 0.00 | 523.4 | -18.6 | 5,448.1 | 22.2 | 8.2 |
| DCM Shriram | 963.75 | 10.9 | 15,029 | 1.17 | 693.4 | 445.4 | 3,564.2 | 9.3 | 11.5 |
| Balmer Lawrie | 156.60 | 9.6 | 2,678 | 5.46 | 70.9 | 3.6 | 748.7 | 10.0 | 14.6 |
| TTK Healthcare | 1,013.90 | 18.7 | 1,433 | 0.97 | 21.3 | 63.7 | 257.6 | 13.8 | 8.0 |
| Empire Inds. | 1,022.00 | 10.9 | 613 | 2.45 | 14.2 | 47.3 | 183.6 | 10.1 | 17.9 |
| Maheshwari Logi. | 70.00 | 13.6 | 207 | 0.00 | 3.3 | -25.8 | 234.9 | -8.4 | 12.0 |
| Median | 1,010.00 | 13.6 | 2,678 | 0.97 | 70.9 | 3.6 | 748.7 | 10.1 | 12.0 |
Competes with: 3M India Limited, Balmer Lawrie & Company Limited, DCM Shriram Limited, Dhunseri Ventures Limited, Empire Industries Limited, Godrej Industries Limited, Maheshwari Logistics Limited
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 202 | 186 | 184 | 181 | 208 | 198 | 205 | 190 | 226 | 204 | 209 | 218 | 258 |
| Expenses | 192 | 176 | 179 | 169 | 201 | 190 | 197 | 178 | 224 | 198 | 202 | 207 | 243 |
| Material Cost | 50 | 50 | 48 | 51 | 51 | 61 | |||||||
| Change in Inventories | -10 | 5.22 | 1.03 | -7.72 | 1.41 | -2.17 | |||||||
| Purchases of Stock-in-Trade | 48 | 47 | 49 | 54 | 53 | 55 | |||||||
| Employee Cost | 36 | 41 | 41 | 42 | 41 | 47 | |||||||
| Other Expenses | 54 | 81 | 59 | 63 | 60 | 82 | |||||||
| Operating Profit | 10 | 10 | 5 | 12 | 7 | 8 | 8 | 12 | 3 | 5 | 7 | 11 | 15 |
| OPM % | 4.97 | 5.13 | 2.90 | 6.86 | 3.32 | 4.15 | 3.75 | 6.30 | 1.18 | 2.62 | 3.41 | 5.06 | 5.72 |
| Other Income | 15 | 16 | 16 | 16 | 37 | 18 | 18 | 13 | 18 | 19 | 10 | 21 | 17 |
| Exceptional items (within Other Income) | -5.86 | 0 | 0 | -7.58 | 3.50 | 0 | |||||||
| Interest | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 21 | 22 | 18 | 24 | 41 | 23 | 23 | 22 | 18 | 21 | 14 | 30 | 29 |
| Tax % | 24 | 26 | 27 | 25 | 23 | 26 | 26 | 26 | 26 | 4 | 25 | 26 | 26 |
| Net Profit | 16 | 16 | 13 | 18 | 32 | 17 | 17 | 16 | 13 | 20 | 11 | 22 | 21 |
| EPS in Rs | 11 | 11 | 9.12 | 13 | 22 | 12 | 12 | 11 | 9.20 | 14 | 7.45 | 15 | 15 |
| Diluted EPS in Rs | 11 | 9.20 | 14 | 7.45 | 15 | 15 |
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 483 | 519 | 528 | 578 | 628 | 646 | 476 | 599 | 725 | 753 | 801 | 857 | 888 |
| Expenses | 453 | 478 | 489 | 535 | 578 | 617 | 457 | 577 | 694 | 715 | 767 | 831 | 850 |
| Material Cost | 195 | 200 | |||||||||||
| Change in Inventories | -13 | -0.06 | |||||||||||
| Purchases of Stock-in-Trade | 187 | 203 | |||||||||||
| Employee Cost | 151 | 165 | |||||||||||
| Other Expenses | 247 | 262 | |||||||||||
| Operating Profit | 30 | 40 | 38 | 43 | 50 | 28 | 19 | 22 | 31 | 37 | 35 | 26 | 38 |
| OPM % | 6 | 8 | 7 | 7 | 8 | 4.40 | 4.10 | 3.60 | 4.30 | 5 | 4.30 | 3 | 4.30 |
| Other Income | 7 | 6 | 6 | 8 | 8 | 9 | 28 | 42 | 643 | 63 | 85 | 68 | 67 |
| Exceptional items (within Other Income) | 14 | -4.07 | |||||||||||
| Interest | 4 | 3 | 3 | 5 | 3 | 3 | 2 | 3 | 5 | 3 | 3 | 2.93 | 3 |
| Depreciation | 6 | 7 | 12 | 15 | 15 | 14 | 13 | 13 | 13 | 13 | 8.33 | 8.76 | 9 |
| Profit before tax | 26 | 36 | 29 | 30 | 39 | 19 | 32 | 48 | 657 | 84 | 108 | 83 | 94 |
| Tax % | 39 | 36 | 36 | 40 | 38 | 37 | -44 | 13 | 3 | 25 | 25 | 20 | |
| Net Profit | 16 | 23 | 19 | 18 | 24 | 12 | 46 | 42 | 640 | 63 | 82 | 66 | 74 |
| EPS in Rs | 21 | 29 | 24 | 13 | 17 | 8.72 | 33 | 29 | 453 | 44 | 58 | 46 | 52 |
| Diluted EPS in Rs | 58 | 46 | |||||||||||
| Dividend Payout % | 22 | 17 | 21 | 39 | 29 | 34 | 18 | 34 | 2 | 22 | 17 | 22 |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- 5%
- 5 years
- 12%
- 3 years
- 6%
- TTM
- 8%
Compounded profit growth
- 10 years
- 12%
- 5 years
- 11%
- 3 years
- -52%
- TTM
- 14%
Stock price CAGR
- 10 years
- 0%
- 5 years
- 9%
- 3 years
- -2%
- 1 year
- -10%
Return on equity
- 10 years
- 19%
- 5 years
- 22%
- 3 years
- 7%
- Last year
- 6%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 110 | 128 | 150 | 219 | 237 | 235 | 281 | 316 | 939 | 987 | 1,051 | 1,101 |
| Borrowings | 42 | 38 | 23 | 47 | 29 | 30 | 19 | 22 | 27 | 23 | 24 | 24 |
| Other Liabilities | 115 | 128 | 104 | 127 | 136 | 152 | 180 | 207 | 189 | 183 | 192 | 190 |
| Total Liabilities | 275 | 303 | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
| Fixed Assets | 52 | 106 | 99 | 110 | 98 | 89 | 85 | 80 | 71 | 75 | 81 | 73 |
| CWIP | 46 | 1 | 0 | 1 | 2 | 9 | 0 | 0 | 3 | 1 | 0 | 1 |
| Investments | 0 | 10 | 9 | 9 | 13 | 9 | 13 | 15 | 13 | 13 | 11 | 9 |
| Other Assets | 177 | 185 | 177 | 288 | 304 | 325 | 395 | 463 | 1,083 | 1,118 | 1,189 | 1,246 |
| Total Assets | 275 | 303 | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 39 | 37 | 18 | 25 | 17 | 20 | 96 | 45 | -25 | -5 | -4 | -21 |
| Cash from Investing Activity | -49 | -27 | 5 | -22 | 10 | -13 | -77 | -30 | 32 | 28 | 20 | 52 |
| Cash from Financing Activity | 3 | -11 | -23 | -7 | -31 | -10 | -17 | -10 | -12 | -22 | -18 | -18 |
| Net Cash Flow | -7 | -0 | 0 | -4 | -4 | -4 | 2 | 5 | -6 | 2 | -2 | 13 |
| Free Cash Flow | -10 | 21 | 12 | 21 | 13 | 8 | 95 | 42 | -36 | -15 | 6 | -25 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 34 | 33 | 24 | 35 | 47 | 43 | 46 | 33 | 46 | 42 | 41 | 47 |
| Inventory Days | 62 | 66 | 65 | 80 | 77 | 101 | 123 | 102 | 89 | 105 | 107 | 98 |
| Days Payable | 50 | 53 | 100 | 130 | 101 | 121 | 170 | 134 | 116 | 110 | 106 | 83 |
| Cash Conversion Cycle | 46 | 46 | -11 | -16 | 22 | 23 | -2 | 1 | 19 | 36 | 43 | 63 |
| Working Capital Days | -31 | -38 | -24 | -30 | -6 | -3 | -32 | -28 | 4 | 49 | 48 | 161 |
| ROCE % | 20 | 23 | 18 | 15 | 15 | 8 | 6 | 8 | 10 | 9 | 9 | 8 |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
1 when an audit qualification is filed as repetitive
0.00flag
2026-03-31
the company's own unlisted debt securities in default at period end
0.00cr
2026-06-30
the company's own loans / revolving facilities in default at period end (standalone filing)
0.00cr
2026-06-30
net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash
-609inr_cr
2026-03-31
guarantees / comfort given for promoter, promoter group, directors and KMP
0.00cr
2026-03-31
loans outstanding to promoter, promoter group, directors and KMP (governance filing)
0.00cr
2026-03-31
security given for the borrowing of promoter, promoter group, directors and KMP
0.00cr
2026-03-31
News
News and filings about TTK Healthcare Limited. Open one to see why it matters.
No recent news for this company.
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
Competes with
Uses as raw material
- Active pharmaceutical ingredients (valethamate bromide, calcium carbonate, estradiol, dopamine HCl, urokinase)
- Dill seed oil (Woodward's Gripe Water)
- Maize / rice / wheat cereal flour & starch (Foods)
- Natural rubber latex (NR latex)
- Polyisoprene / synthetic rubber latex
- Pyrolytic carbon / titanium alloy (TTK Chitra heart valve components)
Depends on the price of
- corn
- rubber
- wheat
Buys from
- Updater Services Limited · IFM soft services
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Diversified
- Industry
- Diversified
- Classification
- Diversified › Diversified
- ISIN
- INE910C01018
Business segments
- Consumer Products · 28%
- Protective Devices · 25%
- Foods · 18%
- Animal Welfare · 17%
- Medical Devices · 13%
- Others · 0%
Plants
- Hosakote Foods Plant · Hosakote, Bengaluru, Karnataka
- KINFRA International Apparel Park – Heart Valve & Ortho Plant · Thiruvananthapuram (Thumba), Kerala
- Pallavaram Factory · Chennai (Pallavaram), Tamil Nadu
- Pondicherry Condom Manufacturing Plant · Pondicherry, Puducherry
- Virudhunagar Condom Manufacturing Plant · Virudhunagar, Tamil Nadu
News impact
Big market events that reach TTK Healthcare Limited, and how the effect spreads.
30 Sept, 17:51 IST · Market event · medium impact
Cabinet approves 1-10% hike in rabi crops MSPs
The government raised guaranteed prices for winter crops like wheat, so farmers should earn more and village spending may rise, while makers of flour and foods using wheat may pay more.
Who it hits first
- The Union Cabinet (central government's top decision body) raised minimum support prices (guaranteed floor prices the government pays farmers) for winter-sown rabi crops by 1–10%.
- Wheat, the biggest rabi crop, now carries an MSP of Rs 2,610 per quintal (100 kg) against Rs 2,585 last season — about a 1% rise.
- Farmers growing wheat earn a little more per bag sold to the government, while companies that buy wheat pay a little more for it.
Who may gain
- Wheat farmers gain higher guaranteed prices on government purchases, lifting village incomes a notch.
- Rural-facing sellers (foods, staples, farm inputs) benefit as fatter farm cheques support village spending.
- Wheat buyers — biscuit makers, flour millers and restaurant chains — face slightly higher input costs instead of gains.
Along the supply chain
Downstream
Downstream, flour millers, biscuit and noodle makers, and pizza-and-burger chains buy the costlier wheat and choose between absorbing it or raising menu and pack prices.
Upstream
Upstream, farmers and grain handlers supply wheat at the new Rs 2,610 floor; fertilizer and seed sellers may see steadier demand as sowing looks better rewarded.
Where demand moves
Business
Two-way pull: small positive demand as higher farm incomes support rural food and staples volumes, offset by slightly higher wheat costs for millers, bakers and quick-service restaurants.
Capital
No sharp money rotation — a roughly 1% wheat price nudge is too small to re-rate staples or restaurant shares; investors watch margin notes in the next results.
How it spreads across sectors
Consumer Services
Mildly negative: restaurant chains pay more for dough, buns and coatings with no rural-demand offset.
Fast Moving Consumer Goods
Mixed: staples volumes gain from rural incomes while wheat-based margins face a small cost headwind.
Fertilizers
Mildly positive: a better wheat price outlook supports sowing interest and fertilizer demand, though the pack lists no fertilizer makers to size it.
Commodity angle
Commodity
wheat
Move series
wheat
Note
STEP 6.2 fired for wheat (MSP price shock; global wheat at 699.2 US cents/bushel, 1M -9.394%, move used -1.479%), but every dependent row carries null cost weight and null margin bps, so no commodity_impact_bps was copied to any signal.
Shock
price
Unit
US cents/bushel
When it plays out
Immediate
1–7 days: muted share moves; wheat-user margins seen a touch softer, rural-demand hopes a touch firmer.
Medium term
1–6 months: the rabi harvest at the new floor decides actual farm incomes and procurement volumes.
Short term
1–4 weeks: sowing data and management commentary show whether costs pass through to pack and menu prices.
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
Dividends
| 17 Jul 2026 | unspecified | ₹10 |
|---|---|---|
| 18 Jul 2025 | unspecified | ₹10 |
| 16 Jul 2024 | unspecified | ₹10 |
| 18 Jul 2023 | unspecified | ₹10 |
| 26 Jul 2022 | unspecified | ₹10 |
| 12 Aug 2021 | unspecified | ₹6 |
| 3 Sep 2020 | unspecified | ₹3 |
| 1 Aug 2019 | unspecified | ₹5 |
Splits, bonuses & buybacks
- daily-prices repair: 9 rows from NSE's archive (replace 1, delete 1, insert 7), 2016-10-30..2026-02-01 (docs/flat_day_repair.md)1× · 30 Oct 2016
Documents
Annual reports, results presentations and earnings calls, straight from the source.
- Annual report · 2025-2627 Jun 2026
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.